HIV infection from receptive oral sex is a rare event, UCSF study confirms

August 14, 2001

A study by researchers from UCSF's Center for AIDS Prevention Studies (CAPS) found the probability of HIV infection through unprotected receptive oral sex with a man to be statistically estimated as zero.

"Our study looked at exclusive receptive oral intercourse with a male partner, and we found that the probability of acquiring HIV through that specific sexual activity is very, very low. Given that the results are based on a relatively small sample, we can not rule out the possibility that the probability of infection is indeed greater than zero," said study lead author Kimberly Page Shafer, PhD, MPH, assistant professor of medicine at UCSF's CAPS.

The study is ongoing and the findings will be amended by the researchers with greater numbers.

"While our study is the first to attempt to systematically define the risk, case reports exist of infections acquired through oral contact. I want to emphasize that, while rare, acquiring HIV infection orally is possible and that many other sexually transmitted diseases (STDs) such as gonorrhea, chlamydia, and syphilis are transmitted orally," added Shafer.

The study, presented today (August 14) at the Second National Prevention Conference in Atlanta, enrolled 198 participants from anonymous testing and counseling sites in San Francisco. The participants, 98 percent male and 100 percent identified as gay or bisexual, reported no anal or vaginal sex and no injection drug use in the six months prior to entering the study. The participants reported a median of two receptive oral intercourse partners and 98 percent reported unprotected receptive oral intercourse.

Twenty percent of the participants reported receptive oral intercourse with an HIV positive partner. Of that group, 89 percent did not use a condom and 40 percent swallowed ejaculate.

The participants were screened for HIV infection and also for recent HIV infection using both the standard test for HIV and a test for HIV that is "detuned" to detect only those HIV infections that have occurred within the six months prior to taking the test.

Out of the 198 participants, only one HIV infection was reported, and that infection had not been recently acquired and could not be attributed to the period of exclusive oral receptive intercourse. No recently acquired HIV infections were reported by any of the other participants in the study. Statistically, the study yielded a zero probability of acquiring HIV orally.
The study's co-authors are Caroline Shiboski, DDS, MPH, PhD, assistant clinical professor in UCSF's School of Dentistry's stomatology department; James W. Dilley, MD, executive director of UCSF's AIDS Health Project; Joyce Balls, project coordinator at UCSF CAPS; Willi McFarland, MD, PhD, San Francisco DPH HIV Seroepidemiology Unit and UCSF Center for AIDS Prevention Studies; Deborah Greenspan, DSc, professor of clinical and oral medicine in UCSF's School of Dentistry's stomatology department; Stephen Shiboski PhD, and Dennis Osmond, PhD, both associate adjunct professors in UCSF's Department of Epidemiology and Biostatistics.

The study is funded by the National Institute of Dental and Craniofacial Research.

University of California - San Francisco

Related HIV Articles from Brightsurf:

BEAT-HIV Delaney collaboratory issues recommendations measuring persistent HIV reservoirs
Spearheaded by Wistar scientists, top worldwide HIV researchers from the BEAT-HIV Martin Delaney Collaboratory to Cure HIV-1 Infection by Combination Immunotherapy (BEAT-HIV Collaboratory) compiled the first comprehensive set of recommendations on how to best measure the size of persistent HIV reservoirs during cure-directed clinical studies.

The Lancet HIV: Study suggests a second patient has been cured of HIV
A study of the second HIV patient to undergo successful stem cell transplantation from donors with a HIV-resistant gene, finds that there was no active viral infection in the patient's blood 30 months after they stopped anti-retroviral therapy, according to a case report published in The Lancet HIV journal and presented at CROI (Conference on Retroviruses and Opportunistic Infections).

Children with HIV score below HIV-negative peers in cognitive, motor function tests
Children who acquired HIV in utero or during birth or breastfeeding did not perform as well as their peers who do not have HIV on tests measuring cognitive ability, motor function and attention, according to a report published online today in Clinical Infectious Diseases.

Efforts to end the HIV epidemic must not ignore people already living with HIV
Efforts to prevent new HIV transmissions in the US must be accompanied by addressing HIV-associated comorbidities to improve the health of people already living with HIV, NIH experts assert in the third of a series of JAMA commentaries.

The Lancet HIV: Severe anti-LGBT legislations associated with lower testing and awareness of HIV in African countries
This first systematic review to investigate HIV testing, treatment and viral suppression in men who have sex with men in Africa finds that among the most recent studies (conducted after 2011) only half of men have been tested for HIV in the past 12 months.

The Lancet HIV: Tenfold increase in number of adolescents on HIV treatment in South Africa since 2010, but many still untreated
A new study of more than 700,000 one to 19-year olds being treated for HIV infection suggests a ten-fold increase in the number of adolescents aged 15 to 19 receiving HIV treatment in South Africa, according to results published in The Lancet HIV journal.

Starting HIV treatment in ERs may be key to ending HIV spread worldwide
In a follow-up study conducted in South Africa, Johns Hopkins Medicine researchers say they have evidence that hospital emergency departments (EDs) worldwide may be key strategic settings for curbing the spread of HIV infections in hard-to-reach populations if the EDs jump-start treatment and case management as well as diagnosis of the disease.

NIH HIV experts prioritize research to achieve sustained ART-free HIV remission
Achieving sustained remission of HIV without life-long antiretroviral therapy (ART) is a top HIV research priority, according to a new commentary in JAMA by experts at the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health.

The Lancet HIV: PrEP implementation is associated with a rapid decline in new HIV infections
Study from Australia is the first to evaluate a population-level roll-out of pre-exposure prophylaxis (PrEP) in men who have sex with men.

Researchers date 'hibernating' HIV strains, advancing BC's leadership in HIV cure research
Researchers have developed a novel way for dating 'hibernating' HIV strains, in an advancement for HIV cure research.

Read More: HIV News and HIV Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to